Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland-Reference-Cited by-同舟云学术

Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland

Author:

Aaltonen KJ¹,Joensuu JT¹,Pirilä L²,Kauppi M³⁴,Uutela T⁵,Varjolahti-Lehtinen T⁶,Yli-Kerttula T⁷,Isomäki P⁴⁸,Nordström D⁹¹⁰,Sokka T¹¹¹²

Affiliation:

1. Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

2. Department of Medicine, Turku University Hospital, Turku, Finland

3. Department of Medicine, Lahti Central Hospital, Lahti, Finland

4. Faculty of Medicine, University of Tampere, Tampere, Finland

5. Department of Medicine, Lapland Central Hospital, Rovaniemi, Finland

6. Department of Medicine, Tampere City Hospital, Tampere, Finland

7. Department of Medicine, Satakunta Central Hospital, Rauma, Finland

8. Department of Medicine, Tampere University Hospital, Tampere, Finland

9. Department of Medicine, Helsinki University Hospital, Helsinki, Finland

10. Faculty of Medicine, Clinicum, University of Helsinki, Helsinki, Finland

11. Department of Medicine, Jyväskylä Central Hospital, Jyväskylä, Finland

12. Faculty of Health Science, University of Eastern Finland, Kuopio, Finland

Funder

Merck

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

Reference13 articles.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献